SCHEMBL28984095

SCHEMBL28984095

COC(=O)CCN(C(N)=O)c1nn(C)c2c([N+](=O)[O-])cccc12

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ TNF P01375 1/20 0.35
▸ TXNRD1 Q16881 1/20 0.34
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ GSTP1 P09211 1/20 0.33
▸ GSTM2 P28161 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28984104 0.84 DDB1 (0.35) ALDH1A1MEN1KMT2AMAPK1GAA
SCHEMBL28984087 0.76 LMNA (0.52) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL31254097 0.76 LMNA (0.52) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL31330812 0.71 KDM4E (0.39) MEN1KMT2AL3MBTL1LMNAMAPT
SCHEMBL29153133 0.68 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AMAPK1L3MBTL1
SCHEMBL31554609 0.68 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL31330879 0.68 TDP1 (0.47) ALDH1A1MEN1KMT2AMAPK1L3MBTL1
SCHEMBL28984105 0.67 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL30472894 0.67 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL13106231 0.66 TDP1 (0.48) ALDH1A1MAPK1L3MBTL1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115968293-A Cereblon binding compounds, compositions thereof, and methods of use thereof for treatment 新基公司 2023-04-14 — — CN disclosed
Send feedback